Artificial tears: biological role of their ingredients in the management of dry eye disease

M Labetoulle, JM Benitez-del-Castillo… - International journal of …, 2022 - mdpi.com
Dry eye disease (DED) is the most common ocular surface disease, characterized by
insufficient production and/or instability of the tear film. Tear substitutes are usually the first …

Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy—an overview on recent advances

S Jacob, AB Nair, J Shah, S Gupta, SHS Boddu… - Pharmaceutics, 2022 - mdpi.com
Due to complicated anatomical and physical properties, targeted drug delivery to ocular
tissues continues to be a key challenge for formulation scientists. Various attempts are …

[HTML][HTML] Recent developments of nanostructures for the ocular delivery of natural compounds

MS Razavi, P Ebrahimnejad, Y Fatahi… - Frontiers in …, 2022 - frontiersin.org
Ocular disorders comprising various diseases of the anterior and posterior segments are
considered as the main reasons for blindness. Natural products have been identified as …

Tacrolimus loaded cationic liposomes for dry eye treatment

X Chen, J Wu, X Lin, X Wu, X Yu, B Wang… - Frontiers in …, 2022 - frontiersin.org
Eye drops are ophthalmic formulations routinely used to treat dry eye. However, the low
ocular bioavailability is an obvious drawback of eye drops owing to short ocular retention …

Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

Q Qi, Y Wei, X Zhang, J Guan, S Mao - Journal of Controlled Release, 2023 - Elsevier
Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic
retinopathy (DR) are vital factor that seriously threatens human vision health and quality of …

Lipid-based drug delivery systems for diseases managements

DL Gbian, A Omri - Biomedicines, 2022 - mdpi.com
Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which
facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active …

Overview of recent advances in nano-based ocular drug delivery

LC Liu, YH Chen, DW Lu - International Journal of Molecular Sciences, 2023 - mdpi.com
Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …

Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin A for dry eye diseases

KY Wong, Y Liu, L Zhou, MS Wong, J Liu - Journal of Materials …, 2023 - pubs.rsc.org
Traditional eye drops are convenient to use; however, their effectiveness is limited by their
poor retention time and bioavailability in the eyes due to ocular barriers. Therefore …

Trans-corneal drug delivery strategies in the treatment of ocular diseases

L Li, F Jia, Y Wang, J Liu, Y Tian, X Sun, Y Lei… - Advanced Drug Delivery …, 2023 - Elsevier
The cornea is a remarkable tissue that possesses specialized structures designed to
safeguard the eye against foreign objects. However, its unique properties also make it …

[HTML][HTML] Microneedle-based ocular drug delivery systems–recent advances and challenges

P Gadziński, A Froelich, M Wojtyłko… - Beilstein Journal of …, 2022 - beilstein-journals.org
Eye diseases and injuries constitute a significant clinical problem worldwide. Safe and
effective delivery of drugs to the eye is challenging mostly due to the presence of ocular …